UCL Institute of Neurology
Research and teaching excellence
The Institute of Neurology has a world class reputation for neuroscience. The mission is to translate neuroscience discovery research into treatments for patients with neurological diseases. A number of important research centres are based at the Institute, including the MRC Centre for Neuromuscular Diseases and the Wellcome Centre for Human Neuroimaging
The hub of the research activities and operational headquarters of the UK Dementia Research Institute (DRI) are also at UCL, embedded within the Institute.
Professor Michael Hanna is the Director of the Institute, which is a specialist postgraduate institute of University College London, the top-ranked university in the UK for research in Psychology, Psychiatry and Neuroscience.
The Institute is closely associated in its work with the National Hospital for Neurology & Neurosurgery. In combination they form a national and international centre at Queen Square for teaching, training and research in neurology and allied clinical and basic neurosciences.
What We Do
Please see our Infographic highlighting key data on the Institute.
PhD Studentship – Metacognition and decision-making capacity in health and neuropsychiatric disorders
Applications are invited for a PhD studentship in the Wellcome Centre for Human Neuroimaging, UCL as part of the Metacognition Group (www.metacoglab.org), under the supervision of Dr Stephen Fleming (University College London) and Prof. Anthony David (Kings College London). The current project is part of a larger Collaborative Award from the Wellcome Trust (https://mhj.org.uk/) aimed at forming a research base for an interdisciplinary understanding of decision-making capacity.
Published: Aug 16, 2017 4:33:02 PM
UCL researchers are the first to carry out brain imaging of focal cortical epileptic seizures in the awake brain
A team of researchers, led by Professors Dimitri Kullmann (UCL Institute of Neurology) and Matteo Carandini (UCL Institute of Ophthalmology), has developed a method of imaging brain activity to discover how it spreads during a focal cortical epileptic seizure. They were also able to then relate their propagation to cortical connectivity.
Published: Aug 16, 2017 9:33:52 AM
A drug commonly used to treat diabetes may have disease-modifying potential to treat Parkinson’s disease, a new UCL-led study suggests, paving the way for further research to define its efficacy and safety.
Published: Aug 4, 2017 5:33:56 PM